United States · FDA National Drug Code directory

ZEPZELCA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68727-712_846f5d71-faab-42a5-85d6-d83626b7bf3c
Product NDC
68727-712
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Composition / generic term
Lurbinectedin
Labeler
Jazz Pharmaceuticals, Inc.
Marketing category
NDA
Marketing start / end (source format)
20200615
Source listing expiry
20271231

Source-listed ingredients

  • LURBINECTEDIN — .5 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 8 mL in 1 VIAL, SINGLE-DOSE (68727-712-01) · 68727-712-01

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →